Article Versions Notes

Tuninetti V, Ghisoni E, Pignata S, Picardo E, Raspagliesi F, Andreetta C, Maldi E, Artioli G, Mammoliti S, Zanchi L, et al. Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. Cancers. 2023; 15(4):1032. https://doi.org/10.3390/cancers15041032

Tuninetti, Valentina, Eleonora Ghisoni, Sandro Pignata, Elisa Picardo, Francesco Raspagliesi, Claudia Andreetta, Elena Maldi, Grazia Artioli, Serafina Mammoliti, Lucia Zanchi, and et al. 2023. "Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study" Cancers 15, no. 4: 1032. https://doi.org/10.3390/cancers15041032

Tuninetti, V., Ghisoni, E., Pignata, S., Picardo, E., Raspagliesi, F., Andreetta, C., Maldi, E., Artioli, G., Mammoliti, S., Zanchi, L., Sikokis, A., Biglia, N., Parisi, A., Mandato, V. D., Carella, C., Cormio, G., Marinaccio, M., Puppo, A., Paolini, B., ... Valabrega, G. (2023). Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. Cancers, 15(4), 1032. https://doi.org/10.3390/cancers15041032